Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


04.02.2019

1 AIDS
2 Clin Infect Dis
1 J Immunol
2 J Infect Dis
1 Lancet
2 Lancet Glob Health
2 MMWR Morb Mortal Wkly Rep
1 Nat Med
5 PLoS One
16 Vaccine
2 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MACHIELS JD, Braam EE, van Bentum P, van Vugt M, et al
    Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate.
    AIDS. 2019;33:503-507.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. HASSO-AGOPSOWICZ M, Ladva CN, Lopman B, Sanderson C, et al
    Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination.
    Clin Infect Dis. 2019 Jan 28. pii: 5303786. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. DIALLO A, Diop OM, Diop D, Niang MN, et al
    Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial.
    Clin Infect Dis. 2019 Jan 28. pii: 5303780. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Immunol

  4. FORSYTH KS, DeHaven B, Mendonca M, Paul S, et al
    Poor Antigen Processing of Poxvirus Particles Limits CD4(+) T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.
    J Immunol. 2019 Jan 30. pii: jimmunol.1801099. doi: 10.4049/jimmunol.1801099.
    PubMed     Text format     Abstract available


    J Infect Dis

  5. ADLER H, Nikolaou E, Gould K, Hinds J, et al
    Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010-2017.
    J Infect Dis. 2019 Jan 28. pii: 5303784. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
    Infrequent Transmission of Monovalent Human Rotavirus Vaccine Virus to Household Contacts of Vaccinated Infants in Malawi.
    J Infect Dis. 2019 Jan 24. pii: 5300242. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet

  7. CHANDLER J
    Fighting a polio outbreak in Papua New Guinea.
    Lancet. 2018;392:2155-2156.
    PubMed     Text format    


    Lancet Glob Health

  8. SCHUCK-PAIM C, Taylor RJ, Alonso WJ, Weinberger DM, et al
    Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study.
    Lancet Glob Health. 2019;7:e249-e256.
    PubMed     Text format     Abstract available

  9. JIT M, Flasche S
    The role of pneumococcal conjugate vaccination in reducing pneumonia mortality.
    Lancet Glob Health. 2019;7:e173-e174.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  10. MCKAY SL, Kambui A, Taulung LA, Tippins A, et al
    Notes From The Field: Mumps Outbreak in a Recently Vaccinated Population - Kosrae, Federated States of Micronesia, August-December, 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:95-96.
    PubMed     Text format    

  11. HESSE EM, Shimabukuro TT, Su JR, Hibbs BF, et al
    Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018.
    MMWR Morb Mortal Wkly Rep. 2019;68:91-94.
    PubMed     Text format     Abstract available


    Nat Med

  12. YAMAYOSHI S, Kawaoka Y
    Current and future influenza vaccines.
    Nat Med. 2019 Jan 28. pii: 10.1038/s41591-018-0340.
    PubMed     Text format     Abstract available


    PLoS One

  13. ESPANA G, Hogea C, Guignard A, Ten Bosch QA, et al
    Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.
    PLoS One. 2019;14:e0210041.
    PubMed     Text format     Abstract available

  14. CASAL J, Saegerman C, Bertagnoli S, Meyer G, et al
    A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France.
    PLoS One. 2019;14:e0210317.
    PubMed     Text format     Abstract available

  15. ROCKSTROH JK, Asmuth D, Pantaleo G, Clotet B, et al
    Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
    PLoS One. 2019;14:e0210965.
    PubMed     Text format     Abstract available

  16. CUI J, O'Connell CM, Costa A, Pan Y, et al
    A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0208801.
    PubMed     Text format     Abstract available

  17. YUN JW, Choi MJ, Shin GS, Lim JO, et al
    Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    PLoS One. 2019;14:e0209643.
    PubMed     Text format     Abstract available


    Vaccine

  18. GARON J, Wuddhika IV, Sreenivasan N, Wannemuehler K, et al
    Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Vaccine. 2019 Jan 24. pii: S0264-410X(19)30008.
    PubMed     Text format     Abstract available

  19. SURYADEVARA M, Bonville CA, Cibula DA, Domachowske JB, et al
    Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30099.
    PubMed     Text format     Abstract available

  20. WARRELL MJ
    Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30073.
    PubMed     Text format     Abstract available

  21. GHORBANI A, Ngunjiri JM, Xia M, Elaish M, et al
    Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30100.
    PubMed     Text format     Abstract available

  22. NOLAN T, Santolaya ME, de Looze F, Marshall H, et al
    Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30028.
    PubMed     Text format     Abstract available

  23. SHEN AK, Warnock R, Selna W, MaCurdy TE, et al
    Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30041.
    PubMed     Text format     Abstract available

  24. TORISU H, Okada K
    Vaccination-associated acute disseminated encephalomyelitis.
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30075.
    PubMed     Text format     Abstract available

  25. LU J, Luo M, Yee AZH, Sheldenkar A, et al
    Do superstitious beliefs affect influenza vaccine uptake through shaping health beliefs?
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30071.
    PubMed     Text format     Abstract available

  26. LYONS NA, Knight-Jones TJD, Bartels C, Paton DJ, et al
    Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30043.
    PubMed     Text format     Abstract available

  27. SMITHSON MW, Basinki AJ, Nuismer SL, Bull JJ, et al
    Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.
    Vaccine. 2019 Jan 24. pii: S0264-410X(19)30072.
    PubMed     Text format     Abstract available

  28. VADLAMUDI NK, Parhar K, Altre Malana KL, Kang A, et al
    Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30057.
    PubMed     Text format     Abstract available

  29. COELHO CH, Gazzinelli-Guimaraes PH, Howard J, Barnafo E, et al
    Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel(R) in mice.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30090.
    PubMed     Text format     Abstract available

  30. SAHIN Z, Neeleman R, Haines J, Kayser V, et al
    Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30050.
    PubMed     Text format     Abstract available

  31. MILUCKY J, Carvalho MG, Rouphael N, Bennett NM, et al
    Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30070.
    PubMed     Text format     Abstract available

  32. JENDROSSEK M, Edmunds WJ, Rohan H, Clifford S, et al
    Health care worker vaccination against Ebola: Vaccine acceptance and employment duration in Sierra Leone.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30029.
    PubMed     Text format     Abstract available

  33. WILDES TJ, Grippin A, Fasanya H, Dyson KA, et al
    Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial.
    Vaccine. 2019 Jan 24. pii: S0264-410X(19)30077.
    PubMed     Text format     Abstract available


    Virology

  34. YIN L, Chen L, Luo Y, Lin L, et al
    Recombinant fiber-2 protein protects Muscovy ducks against duck adenovirus 3 (DAdV-3).
    Virology. 2019;526:99-104.
    PubMed     Text format     Abstract available

  35. LEE YT, Kim KH, Ko EJ, Kim MC, et al
    Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
    Virology. 2019;529:111-121.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: